Trial Profile
Phase III Open Label Clinical Trial to Assess Efficacy, Safety and Tolerability of Botulinum Toxin A (Xeomin) in Treatment of Expression Wrinkles in the Upper Third of the Face
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Dec 2015
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Skin aging
- Focus Therapeutic Use
- Sponsors Biolab Industrias Farmaceuticas
- 17 Sep 2014 New trial record